Miyanari Yusuke, Hijikata Makoto, Yamaji Masashi, Hosaka Masahiro, Takahashi Hitoshi, Shimotohno Kunitada
Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan.
J Biol Chem. 2003 Dec 12;278(50):50301-8. doi: 10.1074/jbc.M305684200. Epub 2003 Sep 8.
The molecular mechanism of hepatitis C virus(HCV) RNA replication is still unknown. Recently, a cell culture system in which the HCV subgenomic replicon is efficiently replicated and maintained for a long period in Huh-7 cells has been established. Taking advantage of this replicon system, we detected the activity to synthesize the subgenomic RNA in the digitonin-permeabilized replicon cells. To elucidate how and where this viral RNA replicates in the cells, we monitored the activity for HCV RNA synthesis in the permeabilized replicon cells under several conditions. We obtained results suggesting that HCV replication complexes functioning to synthesize the replicon RNA are protected from access of nuclease and proteinase by possible cellular lipid membranes. We also found that a large part of the replicon RNA, including newly synthesized RNA, was present in such a membranous structure but a large part of each NS protein was not. A small part of each NS protein that was resistant to the proteinase action was shown to contribute sufficiently to the synthesis of HCV subgenomic RNA in the permeabilized replicon cells. These results suggested that a major subcellular site of HCV genome replication is probably compartmentalized by lipid membranes and that only a part of each NS protein forms the active replication complex in the replicon cells.
丙型肝炎病毒(HCV)RNA复制的分子机制仍不清楚。最近,已建立了一种细胞培养系统,其中HCV亚基因组复制子在Huh-7细胞中能高效复制并长期维持。利用该复制子系统,我们检测了洋地黄皂苷通透化的复制子细胞中合成亚基因组RNA的活性。为了阐明这种病毒RNA在细胞中的复制方式和位置,我们在几种条件下监测了通透化复制子细胞中HCV RNA合成的活性。我们获得的结果表明,负责合成复制子RNA的HCV复制复合体可能受到细胞脂质膜的保护,免受核酸酶和蛋白酶的作用。我们还发现,包括新合成的RNA在内,大部分复制子RNA存在于这样的膜结构中,但每种NS蛋白的大部分并不存在。对蛋白酶作用具有抗性的每种NS蛋白的一小部分被证明对通透化复制子细胞中HCV亚基因组RNA的合成有足够的贡献。这些结果表明,HCV基因组复制的主要亚细胞位点可能由脂质膜分隔,并且每种NS蛋白只有一部分在复制子细胞中形成活性复制复合体。